Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Tivantinib as second line therapy for high-MET HCC
Prof Lorenza Rimassa - Humanitas Cancer Center, Milan, Italy
Tivantinib as second line therapy for high-MET HCC ( Prof Lorenza Rimassa - Humanitas Cancer Center, Milan, Italy )
4 Jun 2017
3 or 6 months adjuvant oxaliplatin for colorectal cancer
Dr Tim Iveson - University Hospital Southampton, Salisbury, UK
3 or 6 months adjuvant oxaliplatin for colorectal cancer ( Dr Tim Iveson - University Hospital Southampton, Salisbury, UK )
4 Jun 2017
No link between pregnancy and breast cancer relapse
Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium
No link between pregnancy and breast cancer relapse ( Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium )
4 Jun 2017
Cancer and caring in modern medicine
Prof Siddhartha Mukherjee - Columbia University Medical Center, New York, USA
Cancer and caring in modern medicine ( Prof Siddhartha Mukherjee - Columbia University Medical Center, New York, USA )
4 Jun 2017
Pooled analysis of avelumab for metastatic urothelial carcinoma
Dr Andrea Apolo - National Cancer Institute, Bethesda, USA
Pooled analysis of avelumab for metastatic urothelial carcinoma ( Dr Andrea Apolo - National Cancer Institute, Bethesda, USA )
3 Jun 2017
Cancer and living meaningfully: the CALM intervention
Dr Gary Rodin - Princess Margaret Cancer Centre, Toronto, Canada
Cancer and living meaningfully: the CALM intervention ( Dr Gary Rodin - Princess Margaret Cancer Centre, Toronto, Canada )
3 Jun 2017
Larotrectinib shows durable efficacy across diverse paediatric and adult cancers
Dr David Hyman - Memorial Sloan Kettering Cancer Centre, New York, USA
Larotrectinib shows durable efficacy across diverse paediatric and adult cancers ( Dr David Hyman - Memorial Sloan Kettering Cancer Centre, New York, USA )
3 Jun 2017
Routine genomic testing is feasible, but only a subset of patients benefit
Dr Olivier Trédan - Centre Léon Bérard, Lyon, France
Routine genomic testing is feasible, but only a subset of patients benefit ( Dr Olivier Trédan - Centre Léon Bérard, Lyon, France )
3 Jun 2017
Molecular profiles and the future of adjuvant therapy
Dr Rodrigo Dienstmann - Vall d’Hebron Institute of Oncology, Barcelona, Spain
Molecular profiles and the future of adjuvant therapy ( Dr Rodrigo Dienstmann - Vall d’Hebron Institute of Oncology, Barcelona, Spain )
3 Jun 2017
Pregnancy after breast cancer no associated with relapse risk
Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium
Pregnancy after breast cancer no associated with relapse risk ( Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium )
3 Jun 2017
Recent childhood cancer survivors face less chronic disease risk than previous...
Dr Todd Gibson - St Jude Children's Research Hospital, Memphis, USA
Recent childhood cancer survivors face less chronic disease risk than previous decades ( Dr Todd Gibson - St Jude Children's Research Hospital, Memphis, USA )
2 Jun 2017
Steady decrease in severe health problems for childhood cancer survivors
Dr Todd M. Gibson - St Jude Children's Research Hospital, Memphis, USA
Steady decrease in severe health problems for childhood cancer survivors ( Dr Todd M. Gibson - St Jude Children's Research Hospital, Memphis, USA )
2 Jun 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation